Skip to main content
Premium Trial:

Request an Annual Quote

Biosite and Oxford Partner on Colorectal Cancer Biomarker Study

NEW YORK, April 4 (GenomeWeb News) - Biosite and Oxford Genome Sciences today said they will co-evaluate protein-based disease markers for colorectal cancer.


Under the terms of the collaboration, Oxford will identify at least 25 proteins from blood and tissue samples from relapsing colorectal cancer patients, and Biosite will have the rights to develop blood-based diagnostic tests using one or more of the biomarkers.


Financial terms of the agreement were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.